CNS lymphoma · 4 regimens
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
High-dose Cytarabine monotherapy (HiDAC) Variant #01 | — | R 26 364 | — | ~5.2 mo | — | — | — | 1 |
Cytarabine and Etoposide (CYVE) Variant #06 | — | R 11 761 | — | — | ~9.2 mo | — | — | — |
Ifosfamide and Methotrexate Variant #01 | — | R 8 658 | — | — | — | — | — | — |
Whole brain irradiation N/A - radiation Partial | — | — | 21d | — | — | — | — | 1 |
4 of 4 regimens shown